Objectives:
The objective of this study was to establish an open source platform for NIPT based on Massive Parallel whole-genome Sequencing (MPS) in a public setting. Methods: MPS was performed on circulating cell-free DNA from 205 selected pregnant women with known fetal karyotypes. The pipeline included automated library preparation and sequencing on a HiSeq1500 (Illumina). WISECONDOR and SeqFF were used for data analysis of aneuploidies, fetal sex and fetal fraction (FF) . Data analysis for aneuploidy and fetal sex were accepted in samples with FF above 0.02 and 0.025, respectively. Samples with FF below cut-off were described as 'no-calls'. Results: The NIPT results were positive for T21 in 44 of 46 T21 cases. The two negative T21 cases were 'no-calls' due to low FF. Among 19 T18 cases 14 were NIPT positive of which two cases were identified even though FF were too low. Two samples were 'no-calls' and three samples were false negative, which could be explained by a vanished twin or IVF treatment. Finally, seven out of eight T13 cases were positive, though one case had a low FF. The false negative T13 sample is probably explained by a vanished twin. Among normal karyotypes we found four false positive cases. Fetal sex was analysed in 189 samples (FF<0.025 excluded) and was correctly identified in all 94 females. Fetal sex was correctly identified in 92 out of 95 male fetuses. Two of the incorrectly results might be due to a vanished twin and a very high maternal BMI. Conclusions: Our study shows that screening for fetal aneuploidy and sex can be done by our fully automated NIPT pipeline. The sensitivity for T21 was 100% but lower for T18 and T13. This study demonstrates that FF, a vanished twin, BMI and perhaps IVF are important factors that should be taken into consideration in the interpretation of NIPT results. Objectives: Chromosomal microarray (CMA) analysis is effectively applied prenatally to detect copy number changes. SNP probes included on the microarray platform can detect regions of excessive homozygosity (ROH) and identical-by-descent genomic stretches. The utility of the latter in prenatal diagnosis is not well established. Recessive founder mutations have been identified within distinct ethnic groups. Combining these data with prenatal sonography provides accurate molecular diagnoses quickly.
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Methods: Three gravidae presenting with specific fetal sonographic findings: 1) ventriculomegaly with encephalocele; 2) severe polyhydramnion, and 3) enlarged echogenic kidneys, underwent amniocentesis for CMA, and Genome-Wide Human SNP array was used to analyse DNA from amniocytes. The Genomic Oligoarray and SNP array evaluation tool v3.0 was used to detect recessive loci associated with the reported clinical findings. Candidate regions were further interrogated using the National Genetic Database. Results: Three fetuses from three distinct nuclear families in which the parents shared a similar ethnicity (either Ashkenazi or Bukharan Jews) but no reported consanguinity, were assessed. No copy number changes were observed, however evaluation of regions of homozygosity revealed a relevant candidate gene for the specific phenotype for each fetus. Using the National Genetic Database a specific mutation was examined in both parents (c.1167dupA mutation in the FKTN gene, c.167ins6[TTTCCC] mutation in the BSND gene and c.3761_3762delCCinsG in the PKHD1 gene, respectively). Both parents were found to be carriers and the fetuses homozygotes to the mutation. Conclusions: For the first time, specific sonographic pathology, data from ROH extracted from CMA results, and information regarding common founder mutations in distinct ethnic subgroups were combined to create a comprehensive streamlined approach to provide effective genetic diagnosis and counselling within the time constraints of ongoing pregnancy. Objectives: Prior to 2012, detection of major CHA had been based mainly on combined first trimester or integrated screening and ultrasound examinations. High-risk cases had been offered invasive diagnostics and karyotyping. The implementation of non-invasive prenatal screening (NIPS) might lead to a decrease of invasive tests causing lower accidental detection of other autosomal aberrations than trisomies 21,18,13 in the population. We tested the hypothesis, that the ratio of prenatally diagnosed CHA has been changed since the gradual implementation of NIPS after 2012. Methods: We used data from the National Registry of Congenital Anomalies including the individually collected data on prenatally diagnosed cases. We have analysed the prenatally diagnosed cases of all CHA (ICD-10 codes: Q90-Q99) during the 2012-2015 time period. The numbers were evaluated for the group of main autosomal trisomies and ''other'' CHA separately. The time trends were statistically evaluated using GraphPad InStat statistical software. Results: The number of invasive procedures, amniocenteses and chorion biopsies decreased from 11407 in the year 2012 to 7680 in 2015. A total of 575 cases of CHA were identified in 2012, of which 329 cases (57.5%) were trisomies 21, 18 and 13. In 2015, 577 cases of all CHA were identified, with major trisomies contributing 374 cases (64.8%). Thus there was no significant change in the proportion of group of major autosomal trisomies, compared to the ''other'' CHA (p>0.05). During the study period the total number of prenatally diagnosed CHA was 2369; major trisomies contributed 1462 cases (76.3%). Conclusions: We were not able to confirm, that the implementation of NIPS with consequent decrease of invasive procedures would lead to less recognition of other unbalanced CHA, that could also have severe phenotypical features for the fetus and/or infant. The overall ratio of prenatally diagnosed trisomies 21,13,18 and ''other'' autosomal aberrations remained unchanged.
Supported by the Ministry of Health of the Czech Republic RVO VFN64165 and 17-29622A. lead to 'no-call' results (6%). In four euploid cases the reason was technical (BAD cluster) and in nine cases FF was below cut-off (0.02). The gestational age among 'no-calls' ranged from 12 weeks + 3 days to 15 weeks + 2 days. The number of reads ranged from 8 to 34 mio. In the group of 'no-calls' caused by low FF two cases had a maternal BMI>40, four cases had a BMI between 30 and 40, and three cases had a BMI<30. Furthermore, in the group of cases with low FF we found a high number of aneuploidy cases (T21=2, T18=4, T13=1, euploid=2). The Z-scores (ChrW) among the seven aneuploidy cases with a low FF ranged from 0.08 to 6 (cut-off=3). Two cases of T18 and one case of T13 had a Z-score >3 despite a low FF. If the fetal fraction had not been determined four aneuploidy cases might have been false negative. Conclusions: High maternal BMI and fetal aneuploidy highly influence the risk of a 'no-call' result. Therefore, labs performing NIPT in a population with a high number of obese women might have a higher 'no-call' rate. We found a high number of aneuploidy cases among 'no-calls'. Only T18 and T13 are described in the literature to have decreased FF. If we had not included determination of FF in our set-up, four cases might have been false negative.
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